Timing, rather than the concentration of cyclic AMP, correlates to osteogenic differentiation of human mesenchymal stem cells

R. Siddappa, J. Doorn, J. Liu, Eli Langerwerf, Roel Arends, Clemens van Blitterswijk, Jan de Boer

Research output: Contribution to journalArticleAcademic

20 Citations (Scopus)

Abstract

Previously, we demonstrated that protein kinase A (PKA) activation using dibutyryl-cAMP in human mesenchymal stem cells (hMSCs) induces in vitro osteogenesis and bone formation in vivo. To further investigate the physiological role of PKA in hMSC osteogenesis, we tested a selection of G-protein-coupled receptor ligands which signal via intracellular cAMP production and PKA activation. Treatment of hMSCs with parathyroid hormone, parathyroid hormone-related peptide, melatonin, epinephrine, calcitonin or calcitonin gene-related peptide did not result in accumulation of cAMP or induction of alkaline phosphatase (ALP) expression. The only ligand that did induce cAMP, prostaglandin E2, even inhibited ALP expression and mineralization, suggesting that physiological levels of cAMP may inhibit osteogenesis. Furthermore, intermittent exposure of hMSCs to dibutyryl-cAMP inhibited ALP expression, whereas we did not observe an inhibitive effect at low dibutyryl-cAMP concentrations. Taken together, our results demonstrate that cAMP can either stimulate or inhibit osteogenesis in hMSCs, depending on the duration, rather than the strength, of the signal provided.
Original languageUndefined
Pages (from-to)356-365
JournalJournal of tissue engineering and regenerative medicine
Volume4
Issue number5
DOIs
Publication statusPublished - 2010

Keywords

  • parathyroid hormone
  • IR-72586
  • osteogenic differentiation
  • GPCR ligands
  • Human mesenchymal stem cells
  • prostaglandin E2
  • protein kinase A

Cite this

Siddappa, R. ; Doorn, J. ; Liu, J. ; Langerwerf, Eli ; Arends, Roel ; van Blitterswijk, Clemens ; de Boer, Jan. / Timing, rather than the concentration of cyclic AMP, correlates to osteogenic differentiation of human mesenchymal stem cells. In: Journal of tissue engineering and regenerative medicine. 2010 ; Vol. 4, No. 5. pp. 356-365.
@article{588ca89719a0407ca7bdb304e1737106,
title = "Timing, rather than the concentration of cyclic AMP, correlates to osteogenic differentiation of human mesenchymal stem cells",
abstract = "Previously, we demonstrated that protein kinase A (PKA) activation using dibutyryl-cAMP in human mesenchymal stem cells (hMSCs) induces in vitro osteogenesis and bone formation in vivo. To further investigate the physiological role of PKA in hMSC osteogenesis, we tested a selection of G-protein-coupled receptor ligands which signal via intracellular cAMP production and PKA activation. Treatment of hMSCs with parathyroid hormone, parathyroid hormone-related peptide, melatonin, epinephrine, calcitonin or calcitonin gene-related peptide did not result in accumulation of cAMP or induction of alkaline phosphatase (ALP) expression. The only ligand that did induce cAMP, prostaglandin E2, even inhibited ALP expression and mineralization, suggesting that physiological levels of cAMP may inhibit osteogenesis. Furthermore, intermittent exposure of hMSCs to dibutyryl-cAMP inhibited ALP expression, whereas we did not observe an inhibitive effect at low dibutyryl-cAMP concentrations. Taken together, our results demonstrate that cAMP can either stimulate or inhibit osteogenesis in hMSCs, depending on the duration, rather than the strength, of the signal provided.",
keywords = "parathyroid hormone, IR-72586, osteogenic differentiation, GPCR ligands, Human mesenchymal stem cells, prostaglandin E2, protein kinase A",
author = "R. Siddappa and J. Doorn and J. Liu and Eli Langerwerf and Roel Arends and {van Blitterswijk}, Clemens and {de Boer}, Jan",
year = "2010",
doi = "10.1002/term.246",
language = "Undefined",
volume = "4",
pages = "356--365",
journal = "Journal of tissue engineering and regenerative medicine",
issn = "1932-6254",
publisher = "Wiley",
number = "5",

}

Timing, rather than the concentration of cyclic AMP, correlates to osteogenic differentiation of human mesenchymal stem cells. / Siddappa, R.; Doorn, J.; Liu, J.; Langerwerf, Eli; Arends, Roel; van Blitterswijk, Clemens; de Boer, Jan.

In: Journal of tissue engineering and regenerative medicine, Vol. 4, No. 5, 2010, p. 356-365.

Research output: Contribution to journalArticleAcademic

TY - JOUR

T1 - Timing, rather than the concentration of cyclic AMP, correlates to osteogenic differentiation of human mesenchymal stem cells

AU - Siddappa, R.

AU - Doorn, J.

AU - Liu, J.

AU - Langerwerf, Eli

AU - Arends, Roel

AU - van Blitterswijk, Clemens

AU - de Boer, Jan

PY - 2010

Y1 - 2010

N2 - Previously, we demonstrated that protein kinase A (PKA) activation using dibutyryl-cAMP in human mesenchymal stem cells (hMSCs) induces in vitro osteogenesis and bone formation in vivo. To further investigate the physiological role of PKA in hMSC osteogenesis, we tested a selection of G-protein-coupled receptor ligands which signal via intracellular cAMP production and PKA activation. Treatment of hMSCs with parathyroid hormone, parathyroid hormone-related peptide, melatonin, epinephrine, calcitonin or calcitonin gene-related peptide did not result in accumulation of cAMP or induction of alkaline phosphatase (ALP) expression. The only ligand that did induce cAMP, prostaglandin E2, even inhibited ALP expression and mineralization, suggesting that physiological levels of cAMP may inhibit osteogenesis. Furthermore, intermittent exposure of hMSCs to dibutyryl-cAMP inhibited ALP expression, whereas we did not observe an inhibitive effect at low dibutyryl-cAMP concentrations. Taken together, our results demonstrate that cAMP can either stimulate or inhibit osteogenesis in hMSCs, depending on the duration, rather than the strength, of the signal provided.

AB - Previously, we demonstrated that protein kinase A (PKA) activation using dibutyryl-cAMP in human mesenchymal stem cells (hMSCs) induces in vitro osteogenesis and bone formation in vivo. To further investigate the physiological role of PKA in hMSC osteogenesis, we tested a selection of G-protein-coupled receptor ligands which signal via intracellular cAMP production and PKA activation. Treatment of hMSCs with parathyroid hormone, parathyroid hormone-related peptide, melatonin, epinephrine, calcitonin or calcitonin gene-related peptide did not result in accumulation of cAMP or induction of alkaline phosphatase (ALP) expression. The only ligand that did induce cAMP, prostaglandin E2, even inhibited ALP expression and mineralization, suggesting that physiological levels of cAMP may inhibit osteogenesis. Furthermore, intermittent exposure of hMSCs to dibutyryl-cAMP inhibited ALP expression, whereas we did not observe an inhibitive effect at low dibutyryl-cAMP concentrations. Taken together, our results demonstrate that cAMP can either stimulate or inhibit osteogenesis in hMSCs, depending on the duration, rather than the strength, of the signal provided.

KW - parathyroid hormone

KW - IR-72586

KW - osteogenic differentiation

KW - GPCR ligands

KW - Human mesenchymal stem cells

KW - prostaglandin E2

KW - protein kinase A

U2 - 10.1002/term.246

DO - 10.1002/term.246

M3 - Article

VL - 4

SP - 356

EP - 365

JO - Journal of tissue engineering and regenerative medicine

JF - Journal of tissue engineering and regenerative medicine

SN - 1932-6254

IS - 5

ER -